While CCDC88A, CCDC88C, and NUCB2 expression did not correlate with prognosis in PAAD patients (Figures 1A–C), low expression of NUCB1 was highly associated with lower patient survival rate (Figure 1C). The gene discussed is NUCB1; the disease is pancreatic adenocarcinoma.